產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購 |
---|---|---|---|---|---|---|---|
GC36820-5mg |
|
841205-47-8 |
Ostarine - Glpbio |
0 | 需詢價(jià) | C19H14F3N3O3 | |
GC36819-500mg |
|
2070014-82-1 |
Osimertinib dimesylate - Glpbio |
0 | 需詢價(jià) | C30H41N7O8S2 | |
GC36819-200mg |
|
2070014-82-1 |
Osimertinib dimesylate - Glpbio |
0 | 需詢價(jià) | C30H41N7O8S2 | |
GC36819-100mg |
|
2070014-82-1 |
Osimertinib dimesylate - Glpbio |
0 | 需詢價(jià) | C30H41N7O8S2 | |
GC36819-50mg |
|
2070014-82-1 |
Osimertinib dimesylate - Glpbio |
0 | 需詢價(jià) | C30H41N7O8S2 | |
GC36819-10mg |
|
2070014-82-1 |
Osimertinib dimesylate - Glpbio |
0 | 需詢價(jià) | C30H41N7O8S2 | |
GC36819-5g |
|
2070014-82-1 |
Osimertinib dimesylate - Glpbio |
0 | 需詢價(jià) | C30H41N7O8S2 | |
GC36818-100mg |
|
1431303-72-8 |
ORY-1001(trans) - Glpbio |
0 | 需詢價(jià) | C15H24Cl2N2 | |
GC36818-50mg |
|
1431303-72-8 |
ORY-1001(trans) - Glpbio |
0 | 需詢價(jià) | C15H24Cl2N2 | |
GC36818-5mg |
|
1431303-72-8 |
ORY-1001(trans) - Glpbio |
0 | 需詢價(jià) | C15H24Cl2N2 | |
GC36818-10 mM ( 1 mL in Water) |
|
1431303-72-8 |
ORY-1001(trans) - Glpbio |
0 | 需詢價(jià) | C15H24Cl2N2 | |
GC36817-100mg |
|
158013-41-3 |
ortho-iodoHoechst 33258 - Glpbio |
0 | 需詢價(jià) | C25H23IN6 | |
GC36817-50mg |
|
158013-41-3 |
ortho-iodoHoechst 33258 - Glpbio |
0 | 需詢價(jià) | C25H23IN6 | |
GC36817-10mg |
|
158013-41-3 |
ortho-iodoHoechst 33258 - Glpbio |
0 | 需詢價(jià) | C25H23IN6 | |
GC36817-5mg |
|
158013-41-3 |
ortho-iodoHoechst 33258 - Glpbio |
0 | 需詢價(jià) | C25H23IN6 | |
GC36816-50mg |
|
166734-83-4 |
Ornidazole Levo- - Glpbio |
0 | 需詢價(jià) | C7H10ClN3O3 | |
GC36814-10mg |
|
488847-28-5 |
ORM-10103 - Glpbio |
0 | 需詢價(jià) | C20H16N2O4 | |
GC36814-5mg |
|
488847-28-5 |
ORM-10103 - Glpbio |
0 | 需詢價(jià) | C20H16N2O4 | |
GC36813-5mg |
|
1229437-75-5 |
Orientin-2’’-O-p-trans-coumarate - Glpbio |
0 | 需詢價(jià) | C30H26O13 | |
GC36813-1mg |
|
1229437-75-5 |
Orientin-2’’-O-p-trans-coumarate - Glpbio |
0 | 需詢價(jià) | C30H26O13 | |